Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity

NCT00120055 is registered in ClinicalTrials.gov with University of Oslo School of Pharmacy as lead sponsor.

NCT NCT00120055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00120055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity
Lead sponsor
University of Oslo School of Pharmacy
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2005
Completion date
April 30, 2005
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

myopathy